Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: The case for the fibrinolytic potential
Complicated pleural effusions and empyema with loculation and failed drainage are common clinical problems. In adults, intrapleural fibrinolytic therapy (IPFT) is commonly used with variable results, and therapy remains empiric. Despite the intrapleural use of various plasminogen activators (PAs) -...
Main Authors: | Idell, S, Florova, G, Shetty, S, Tucker, T, Idell, R, Koenig, K, Azghani, A, Rahman, N, Komissarov, A |
---|---|
Format: | Journal article |
Published: |
Lippincott, Williams & Wilkins
2017
|
Similar Items
-
Intrapleural fibrinolytic therapy for empyema and pleural loculation: knowns and unknowns
by: Idell, S, et al.
Published: (2018) -
Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models
by: Komissarov, A, et al.
Published: (2016) -
Medical thoracoscopy versus intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema
by: Asem Hewidy, et al.
Published: (2014-10-01) -
Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema
by: Idell, S, et al.
Published: (2019) -
Intrapleural and plasma processing of LTI-01 (single chain urokinase Plasminogen Activator, scuPA) in a phase 1b trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in patients with Complicated Parapneumonic Effusions (CPE) or empyema
by: Komissarov, A, et al.
Published: (2019)